Ophthalmic Business

Top Story

Nicox, Ora enter into licensing agreement for AC-120 for morning eyelid swelling

February 5, 2016

Nicox has entered into a licensing agreement that grants Ora exclusive worldwide rights for the development and commercialization of Nicox’s AC-120 for the treatment of morning eyelid swelling, according to a press release.

Under the terms of the agreement, Ora will be responsible for development activities and funding of the program through its investment arm.

FDA News

Oculus receives 510(k) clearance for Pentacam AXL

February 5, 2016
The Pentacam AXL has received 510(k) clearance from the FDA, Oculus announced in a press release.The device, which combines anterior segment tomography and optical…
FDA News

FDA acknowledges receipt of Shire’s resubmitted NDA for lifitegrast

February 5, 2016
The FDA has acknowledged receipt of a new drug application resubmitted by Shire for lifitegrast to treat signs and symptoms of dry eye disease, the company announced in…
Business News

Visionary Venture Fund and Advisory Board to support ophthalmology startups

February 4, 2016
OCTANe, a business development accelerator, has launched the Visionary Venture Fund and Advisory Board to assist later-stage ophthalmology startup companies, according…
Business News

Nicox, Ora enter into licensing agreement for AC-120 for morning eyelid swelling

February 5, 2016
Nicox has entered into a licensing agreement that grants Ora exclusive worldwide rights for the development and commercialization of Nicox’s…
FDA News

Oculus receives 510(k) clearance for Pentacam AXL

February 5, 2016
The Pentacam AXL has received 510(k) clearance from the FDA, Oculus announced in a press release.The device, which combines anterior segment…
FDA News

FDA acknowledges receipt of Shire’s resubmitted NDA for lifitegrast

February 5, 2016
The FDA has acknowledged receipt of a new drug application resubmitted by Shire for lifitegrast to treat signs and symptoms of dry eye disease, the…
Business News

Visionary Venture Fund and Advisory Board to support ophthalmology startups

February 4, 2016
OCTANe, a business development accelerator, has launched the Visionary Venture Fund and Advisory Board to assist later-stage ophthalmology startup…
Meeting News CoverageVideo

VIDEO: Surgeon says physician consulting necessary for drug, device development

February 4, 2016
SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum, Richard A. Lewis, MD, discusses his keynote lecture on physician involvement with the eye…

Abbott reports $20.4 billion in 2015 worldwide sales

February 3, 2016
Abbott reported $20.4 billion in worldwide sales for 2015, a 9.1% increase on an operational basis and a 0.8% increase on a reported basis compared…
Glaucoma PerspectivesVideo

VIDEO: Aerie Pharmaceuticals executive gives update on clinical trials in 2016

February 3, 2016
SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum here, Tom Mitro, president and COO of Aerie Pharmaceuticals, gives an…
Business News

Glaukos initiates commercial launch of iStent inject in Canada

February 2, 2016
Glaukos has commercially launched the iStent inject trabecular micro-bypass stent in Canada, according to a press release. Health Canada approved the…
From OSN APAO

Topcon forms business alliance with ifa systems

Ocular Surgery News APAO Edition, February 2016
Topcon announced it has acquired 50.1% shares of ifa systems, according to a press release.Services offered by ifa, located in Germany, include…

Surgical Specialties acquires German needle, suture manufacturer

February 1, 2016
Surgical Specialties Corp. announced in a press release it has acquired all shares of Jestetten, Germany-based FSSB Chirurgische Nadein GMBH (FSSB)…
More Headlines »
morganatic-roan